Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J.M. Zekri
Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients With Metastatic Colorectal Cancer: Case Report
The Open Colorectal Cancer Journal
Related publications
Vascular Endothelial Growth Factor Polymorphisms and Clinical Outcome in Colorectal Cancer Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients
Frontiers in Oncology
Cancer Research
Oncology
Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Reply: Oxaliplatin- Or Irinotecan-Based Chemotherapy for Metastatic Colorectal Cancer in the Elderly
British Journal of Cancer
Cancer Research
Oncology
Perioperative Chemotherapy With or Without Bevacizumab in Patients With Metastatic Colorectal Cancer Undergoing Liver Resection
Clinical Colorectal Cancer
Oncology
Gastroenterology
Effect and Safety of Bevacizumab-Containing Chemotherapy Treatment in Chinese Patients With Metastatic Colorectal Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Bevacizumab Improves Survival in Metastatic Colorectal Cancer Patients With Primary Tumor Resection: A Meta-Analysis
Scientific Reports
Multidisciplinary
